Copyright
©The Author(s) 2022.
World J Psychiatry. Feb 19, 2022; 12(2): 236-263
Published online Feb 19, 2022. doi: 10.5498/wjp.v12.i2.236
Published online Feb 19, 2022. doi: 10.5498/wjp.v12.i2.236
Therapeutic category | Number of episodes of stuttering, n = 86 (%) |
Antipsychotics | |
Clozapine | 30 (34.9) |
Olanzapine | 8 (9.3) |
Risperidone | 4 (4.6) |
Aripiprazole | 3 (3.5) |
Trifluoperazine | 1 (1.2) |
Chlorpromazine | 1 (1.2) |
Fluphenazine | 1 (1.2) |
Levomepromazine | 1 (1.2) |
Anticonvulsants | |
Phenytoin | 2 (2.3) |
Divalproex | 2 (2.3) |
Pregabalin | 2 (2.3) |
Gabapentin | 1 (1.2) |
Lamotrigine | 1 (1.2) |
Central nervous system agents | |
Methylphenidate | 3 (3.5) |
Memantine | 2 (2.3) |
Levodopa | 4 (4.6) |
Dextroamphetamine and amphetamine salts (Adderall®) | 1 (1.2) |
Atomoxetine | 1 (1.2) |
Pemoline | 1 (1.2) |
Antidepressants | |
Sertraline | 3 (3.5) |
Bupropion | 3 (3.5) |
Desipramine | 1 (1.2) |
Bipolar agents | |
Lithium | 3 (3.5) |
Respiratory tract agents | |
Theophylline | 4 (4.6) |
Anxiolytics | |
Alprazolam | 1 (1.2) |
Antineoplastics | |
Methotrexate | 1 (1.2) |
Pyrethrin | 1 (1.2) |
Total | 86 (100) |
- Citation: Nikvarz N, Sabouri S. Drug-induced stuttering: A comprehensive literature review. World J Psychiatry 2022; 12(2): 236-263
- URL: https://www.wjgnet.com/2220-3206/full/v12/i2/236.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i2.236